Targeting tachykinin receptors in neuroblastoma
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.13440
Abstract: Neuroblastoma is the most common extracranial tumor in children. Despite aggressive multimodal treatment, high-risk neuroblastoma remains a clinical challenge with survival rates below 50%. Adding targeted drugs to first-line therapy regimens is a promising approach… read more here.
Keywords: targeting tachykinin; cell lines; neuroblastoma; tachykinin receptor ... See more keywords